Germany· DE-A57-099e41d6443d8ced
Allegro
A frovatriptan product containing frovatriptan, registered in Germany by Berlin-Chemie Ag. The same ATC class is registered in 13 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Frovatriptan is registered in 13 of 19 countries.
Countries holding a registration under ATC N02CC07 (frovatriptan), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 7 of them publish a price we can compare per daily dose
Frovatriptan · ATC N02CC07
13 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of frovatriptan costs, country by country.
Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $1.67 in France to $3.26 in Italy — a ×2.0 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Frovatriptan · price per daily dose (2.5 mg)
USD · FX 28 Sept 2026
- IT Italy$3.26
- FR France$1.67
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Frovatriptan
- Manufacturer
- Berlin-Chemie Ag
- Country
- Germany (DE)
- ATC code
- N02CC07
- ATC class
- Frovatriptan
- Defined daily dose
- 2.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- July 8, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
42 interactions on record for frovatriptan.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Frovatriptan · interactions on record
42 records
- 11 severe
- 13 moderate
- 5 minor
- 12 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Frovatriptan in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFrovatriptan 2.5mg tabletsViatris UK Healthcare Ltd
- ItalyAURADOLISTITUTO LUSO FARMACO D'ITALIA S.P.A.
- CanadaAPO-FROVATRIPTANAPOTEX INC
- IrelandFrovatriptan 2.5mg Film-coated TabletsChanelle Medical Unlimited Company
- NorwayFrovatriptan biogaranBiogaran
- FinlandFrovaptanAvansor Pharma Oy
- United StatesFrovatriptanAmneal Pharmaceuticals NY LLC
- FranceFROVATRIPTAN BIOGARAN 2,5 mg, comprimé pelliculéBIOGARAN
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Eumitan, Frovalan
- Belgium · Frovatex
- Bulgaria · Аворан
- Denmark · Frovatriptan Viatris
- Estonia · Migard
- Finland · Frovaptan, Frovatriptan Sandoz
- France · Frovatriptan Biogaran, Frovatriptan Teva
- United Kingdom (Northern Ireland) · Frovatriptan Chanelle Medical, Frovatriptan Clydesdale Pharma
- Greece · Migralin, Pitunal
- Hungary · Migard, Wurazox
- Ireland · Frovatriptan Chanelle Medical, Frovex
- Italy · Auradol, Frovatriptan Doc Generici
- Luxembourg · Frovatex
- Latvia · Migard
- Netherlands · Fromirex, Frovatriptan Doc Generici
- Portugal · Dorlise
- Slovenia · Frotan
- Slovakia · Frovamen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb9f459b-7cb3-4f94-a116-6c0491515888 GET /v1/drugs/eb9f459b-7cb3-4f94-a116-6c0491515888?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Frovatriptan",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about frovatriptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.